| Net Cash Provided by (Used in) Operating Activities |
$23,625 |
USD |
-82% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$23,600 |
USD |
80% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
4,495,198 |
shares |
-0.2% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$99 |
USD |
254% |
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$8 |
USD |
60% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
1,936,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$536,443 |
USD |
0.48% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
1,936,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$229,000 |
USD |
9.6% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$9,413 |
USD |
16% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |